检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:唐玉彬[1,2] 井丽君[1] 苏楠[2] 杜晓兰[2] 陈林[2] Tang Yubin Jing Lijun Su Nan Du Xiaolan Chen Lin(Department of Emergency Treatment, Lanzhou General Hospital, Lanzhou 730050, Chin State Key Laboratory of Trauma, Burns and Combined Injury, Laboratory of Trauma, Center of Bone Metabolism and Repair, Daping Hospital, Third Military Medical University, Chongqing 400042, China)
机构地区:[1]兰州军区兰州总医院急诊科,730050 [2]第三军医大学大坪医院野战外科研究所创伤实验室骨代谢修复中心创伤烧伤与复合伤国家重点实验室,重庆400042
出 处:《中华实验外科杂志》2016年第11期2597-2598,共2页Chinese Journal of Experimental Surgery
摘 要:目的 对原有盲肠结扎穿孔术(CLP)模型进行改良,使其操作更简便,重复性和一致性更好.方法 用小鼠盲肠分支血管位置作为盲肠结扎位置的标准,将CLP模型分为轻、中、重3组,对比观察不同严重程度组别小鼠生存率.增加液体复苏和广谱抗生素处理因素,观察对重度CLP模型生存率影响.结果 对照组和轻度组72 h生存率为100%,中度组72 h生存率为70%,重度组40h生存率为0.复苏组和抗生素组的全部死亡时间分别为44h和46h,与重度CLP组比较差异无统计学意义(P<0.05).结论 该方法改良CLP模型,可获得不同严重程度表现,操作简便,可重复性和一致性好.液体复苏和广谱抗生素不能明显改变重度CLP模型小鼠生存率.Objective To make cecal ligation plus puncture model more convenient and get better repeatability and consistency by reforming.Methods We observer the different survival rate in three groups of mild,moderate and severe degree.The standard is based on the positions of arterial branches on the cecum.We also observe the changes of survival rate when administrating fluid resuscitation and widespectrum antibiotics.Results The survival rate of mild group and control are 100% at 72 hours,moderate is 70%.The survival rate of severe group is 0 at 40 hours.All mice died in resuscitation and antibiotics group at 44 and 46 hours,that has no significant difference with severe group.Conclusion Different CLP's performances can be gotten by our reforming method.This method is handy to complete and has better repeatability and consistency.The survival rate of severe CLP model can't be improved by fluid resuscitation and wide-spectrum antibiotics.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.200